STOCK TITAN

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Relay Therapeutics (Nasdaq: RLAY) will participate in two fireside chats this March. The first event is at the Cowen 43rd Annual Health Care Conference on March 8, 2023, at 10:30 a.m. ET, and the second is the Barclays Global Healthcare Conference on March 15, 2023, at 4:05 p.m. ET. Both events will be available for live webcasting on Relay Therapeutics’ website under the Events section. Archived replays will be accessible for up to 30 days after each chat. Relay Therapeutics is a clinical-stage precision medicine company focused on innovative drug discovery using its Dynamo™ platform.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month, at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET and the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:05 p.m. ET.

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcasts will be available for up to 30 days following each event.

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter

Contact:
Caroline Glen
617-370-8837
cglen@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com


FAQ

When is Relay Therapeutics participating in the Cowen 43rd Annual Health Care Conference?

Relay Therapeutics will participate in the Cowen 43rd Annual Health Care Conference on March 8, 2023, at 10:30 a.m. ET.

What is the date and time for Relay Therapeutics' participation in the Barclays Global Healthcare Conference?

Relay Therapeutics will participate in the Barclays Global Healthcare Conference on March 15, 2023, at 4:05 p.m. ET.

How can I access the webcasts for the Relay Therapeutics fireside chats?

The webcasts for the Relay Therapeutics fireside chats can be accessed through their website under the Events section.

Will there be a replay available for the Relay Therapeutics fireside chats?

Yes, archived replays of the Relay Therapeutics fireside chats will be available for up to 30 days after each event.

What is the focus of Relay Therapeutics' drug discovery efforts?

Relay Therapeutics focuses on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications.

Relay Therapeutics, Inc.

NASDAQ:RLAY

RLAY Rankings

RLAY Latest News

RLAY Stock Data

787.54M
163.25M
1.71%
98.16%
7.22%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE